Barry Sharples, our Executive Chairman and Co-founder, was one of 10 exclusive global speakers invited to pitch at the invite-only 2024 Longevity Investors Conference in Gstaad, Switzerland. This was...
Micregen is pleased to announce its sponsorship of the 37th International Symposium on Pediatrics Surgical Research 2024, to be held at the Karolinska Institute in Stockholm, Sweden. This conference...
(NECrotizing Enterocolitis-ACceleration of CELl-based & Regenerative medicine Advancements for Translation in neOnates), enhancing the clinical translation of stem cell-based potential...
Micregen are very proud to announce that Prof. Paolo De Coppi, one of our Founding Scientists and Clinical Consultant, has been included as a global leading innovator in TIME Magazine...
One of Micregen’s Founders and Clinical Consultant, Prof. Paolo De Coppi, has been making the news recently. Having his work featured in some of the world’s leading Scientific...
Following the successful presentation last month in London at the “Advanced Therapies 2024 Conference” which discussed Secretomix®’s ability to improve gut and lung structure...
Today marks an exciting moment as we extend a warm and enthusiastic welcome to our newly appointed Managing Director, Dr Athanasios Papadopoulos. With a distinguished career, Dr Papadopoulos brings...
Micregen have won the UK Pharma Awards – Innovation of the Year! Peer reviewed recognition when in the field of Longevity can only help build the life science industry interest in regenerative...